| # | Drug | Count |
|---|---|---|
| 0 | ASPIRIN | 42 |
| 1 | ASPIRIN 325 MG | 40 |
| 2 | ASPIRIN 81 MG | 40 |
| 3 | PREDNISONE | 30 |
| 4 | LEVETIRACETAM | 25 |
| 5 | RIVAROXABAN | 24 |
| 6 | APIXABAN | 23 |
| 7 | METHOTREXATE SODIUM | 23 |
| 8 | CLOPIDOGREL | 17 |
| 9 | LEVETIRACETAM IN SODIUM CHLORIDE | 16 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | GALLIUM GA-68 GOZETOTIDE | 7 | 0.0343 |
| 1 | DOLUTEGRAVIR SODIUM AND LAMIVUDINE | 7 | 0.0019 |
| 2 | AMMONIUM LACTATE | 4 | 0.0018 |
| 3 | DEGARELIX | 7 | 0.0013 |
| 4 | DONANEMAB-AZBT | 4 | 0.0013 |
| 5 | CHLORPROMAZINE | 7 | 0.0011 |
| 6 | BENZTROPINE | 7 | 0.0009 |
| 7 | DOLUTEGRAVIR SODIUM | 7 | 0.0008 |
| 8 | LORLATINIB | 5 | 0.0007 |
| 9 | APIXABAN | 23 | 0.0003 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 61 |
| 1 | Corticosteroid [EPC] | 48 |
| 2 | Factor Xa Inhibitor [EPC] | 47 |
| 3 | Platelet Aggregation Inhibitor [EPC] | 43 |
| 4 | HMG-CoA Reductase Inhibitor [EPC] | 20 |
| 5 | Atypical Antipsychotic [EPC] | 17 |
| 6 | Folate Analog Metabolic Inhibitor [EPC] | 16 |
| 7 | Platinum-based Drug [EPC] | 14 |
| 8 | Proton Pump Inhibitor [EPC] | 13 |
| 9 | Angiotensin 2 Receptor Blocker [EPC] | 12 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Radioactive Diagnostic Agent [EPC] | 7 | 0.0022 |
| 1 | alpha-Hydroxy Acid [EPC] | 4 | 0.0018 |
| 2 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 3 | Selective T Cell Costimulation Blocker [EPC] | 2 | 0.0004 |
| 4 | Recombinant Human Growth Hormone [EPC] | 9 | 0.0004 |
| 5 | Osmotic Diuretic [EPC] | 2 | 0.0004 |
| 6 | Insulin-like Growth Factor-1 Receptor Inhibitor [EPC] | 2 | 0.0003 |
| 7 | Amyloid Beta-directed Antibody [EPC] | 1 | 0.0003 |
| 8 | Catechol-O-Methyltransferase Inhibitor [EPC] | 1 | 0.0002 |
| 9 | PCSK9 Inhibitor [EPC] | 5 | 0.0002 |